{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:08:09Z","timestamp":1781730489476,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970356"],"award-info":[{"award-number":["81970356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81470539"],"award-info":[{"award-number":["81470539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Arterial medial calcification (AMC) is associated with a high incidence of cardiovascular risk in patients with type 2 diabetes and chronic kidney disease. Here, we tested whether hydrogen sulfide (H<jats:sub>2<\/jats:sub>S) can prevent AMC in rats with diabetic nephropathy (DN).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>DN was induced by a single injection of streptozotocin and high-fat diet (45% kcal as fat) containing 0.75% adenine in Sprague\u2013Dawley rats for 8\u00a0weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Rats with DN displayed obvious calcification in aorta, and this was significantly alleviated by Sodium Hydrosulfide (NaHS, a H<jats:sub>2<\/jats:sub>S donor, 50\u00a0\u03bcmol\/kg\/day for 8\u00a0weeks) treatment through decreasing calcium and phosphorus content, ALP activity and calcium deposition in aorta. Interestingly, the main endogenous H<jats:sub>2<\/jats:sub>S generating enzyme activity and protein expression of cystathionine-\u03b3-lyase (CSE) were largely reduced in the arterial wall of DN rats. Exogenous NaHS treatment restored CSE activity and its expression, inhibited aortic osteogenic transformation by upregulating phenotypic markers of smooth muscle cells SM\u03b1-actin and SM22\u03b1, and downregulating core binding factor \u03b1-1 (Cbf\u03b1-1, a key factor for bone formation), protein expressions in rats with DN when compared to the control group. NaHS administration also significantly reduced Stat3 activation, cathepsin S (CAS) activity and TGF-\u03b21 protein level, and improved aortic elastin expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>H<jats:sub>2<\/jats:sub>S may have a clinical significance for treating AMC in people with DN by reducing Stat3 activation, CAS activity, TGF-\u03b21 level and increasing local elastin level.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-02307-9","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T15:07:24Z","timestamp":1634137644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hydrogen sulfide prevents arterial medial calcification in rats with diabetic nephropathy"],"prefix":"10.1186","volume":"21","author":[{"given":"Fang-Zheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Bing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"2307_CR1","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.2174\/1381612820666140212210451","volume":"20","author":"DA Chistiakov","year":"2014","unstructured":"Chistiakov DA, Sobenin IA, Orekhov AN, Bobryshev YV. Mechanisms of medial arterial calcification in diabetes. Curr Pharm Des. 2014;20:5870\u201383.","journal-title":"Curr Pharm Des"},{"key":"2307_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000505717","volume":"51","author":"NM Lioufas","year":"2020","unstructured":"Lioufas NM, Pedagogos E, Hawley CM, Pascoe EM, Elder GJ, Badve SV, Valks A, Toussaint ND. Aortic calcification and arterial stiffness burden in a chronic kidney disease cohort with high cardiovascular risk: baseline characteristics of the impact of phosphate reduction on vascular end-points in chronic kidney disease trial. Am J Nephrol. 2020;51:201\u201315.","journal-title":"Am J Nephrol"},{"key":"2307_CR3","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1161\/ATVBAHA.116.306717","volume":"36","author":"CY Ho","year":"2016","unstructured":"Ho CY, Shanahan CM. Medial arterial calcification: an overlooked player in peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2016;36:1475\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2307_CR4","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1007\/s00125-009-1521-6","volume":"52","author":"WJ Jeffcoate","year":"2009","unstructured":"Jeffcoate WJ, Rasmussen LM, Hofbauer LC, Game FL. Medial arterial calcification in diabetes and its relationship to neuropathy. Diabetologia. 2009;52:2478\u201388.","journal-title":"Diabetologia"},{"key":"2307_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"KA Hruska","year":"2008","unstructured":"Hruska KA, Mathew S, Lund R, Qiu P, Pratt R. Hyperphosphatemia of chronic kidney disease. Kidney Int. 2008;74:148\u201357.","journal-title":"Kidney Int"},{"key":"2307_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1053\/j.ackd.2019.08.014","volume":"26","author":"S Disthabanchong","year":"2019","unstructured":"Disthabanchong S, Srisuwarn P. Mechanims of vascular calcification in kidney dease. Adv Chronic Kidney Dis. 2019;26:417\u201326.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2307_CR7","first-page":"442","volume":"62","author":"A Klimentov\u00e1","year":"2016","unstructured":"Klimentov\u00e1 A, S\u00e1gov\u00e1 I, Pr\u00eddavkov\u00e1 D, Kant\u00e1rov\u00e1 D, Makovick\u00fd P, Sadlo\u0148ov\u00e1 J, Mok\u00e1\u0148 M. Diabetic kidney disease 3rd stage - laboratory markers of mineral bone disorder. Vnitr Lek. 2016;62:442\u20138.","journal-title":"Vnitr Lek"},{"issue":"Suppl 1","key":"2307_CR8","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.5301\/jva.5000532","volume":"17","author":"S Baktiroglu","year":"2016","unstructured":"Baktiroglu S, Yanar F, Ozata IH, Oner G, Ercan D. Arterial disease and vascular access in diabetic patients. J Vasc Access. 2016;17(Suppl 1):S69-71.","journal-title":"J Vasc Access"},{"key":"2307_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.jvs.2015.01.026","volume":"61","author":"GS Georgiadis","year":"2015","unstructured":"Georgiadis GS, Argyriou C, Antoniou GA, Kantartzi K, Kriki P, Theodoridis M, Thodis E, Lazarides MK. Upper limb vascular calcification score as a predictor of mortality in diabetic hemodialysis patients. J Vasc Surg. 2015;61:1529\u201337.","journal-title":"J Vasc Surg"},{"key":"2307_CR10","doi-asserted-by":"publisher","first-page":"E658","DOI":"10.1152\/ajpendo.00204.2019","volume":"317","author":"F Schinzari","year":"2019","unstructured":"Schinzari F, Tesauro M, Bertoli A, Valentini A, Veneziani A, Campia U, Cardillo C. Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. Am J Physiol Endocrinol Metab. 2019;317:E658\u201366.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2307_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/cvr\/cvy010","volume":"114","author":"AL Durham","year":"2018","unstructured":"Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018;114:590\u2013600.","journal-title":"Cardiovasc Res"},{"key":"2307_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41374-018-0076-x","volume":"98","author":"Y Kong","year":"2018","unstructured":"Kong Y, Liang Q, Chen Y, Yang P, Liu X, Li Y, Feng S, Wu J, Liu W, Tang J, Yu H, Ou JS, Lu L, Yan J. Hyaluronan negatively regulates vascular calcification involving BMP2 signaling. Lab Investig. 2018;98:1320\u201332.","journal-title":"Lab Investig"},{"key":"2307_CR13","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.3390\/ijms20174202","volume":"20","author":"YB Zhou","year":"2019","unstructured":"Zhou YB, Zhou H, Li L, Kang Y, Cao X, Wu ZY, Ding L, Sethi G, Bian JS. Hydrogen sulfide prevents elastin loss and attenuates calcification induced by high glucose in smooth muscle cells through suppression of Stat3\/Cathepsin S signaling pathway. Int J Mol Sci. 2019;20:4202.","journal-title":"Int J Mol Sci"},{"key":"2307_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/ars.2011.4005","volume":"17","author":"YH Liu","year":"2012","unstructured":"Liu YH, Lu M, Hu LF, Wong PT, Webb GD, Bian JS. Hydrogen sulfide in the mammalian cardiovascular system. Antioxid Redox Signal. 2012;17:141\u201385.","journal-title":"Antioxid Redox Signal"},{"key":"2307_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1089\/ars.2012.4888","volume":"20","author":"YH Liu","year":"2014","unstructured":"Liu YH, Lu M, Xie ZZ, Hua F, Xie L, Gao JH, Koh YH, Bian JS. Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats. Antioxid Redox Signal. 2014;20:759\u201369.","journal-title":"Antioxid Redox Signal"},{"key":"2307_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/ijms20020313","volume":"20","author":"X Cao","year":"2019","unstructured":"Cao X, Zhang W, Moore PK, Bian J. Protective smell of hydrogen sulfide and polysulfide in cisplatin-induced nephrotoxicity. Int J Mol Sci. 2019;20:313.","journal-title":"Int J Mol Sci"},{"key":"2307_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-319-18144-8_4","volume":"230","author":"G Yang","year":"2015","unstructured":"Yang G, Wang R. H2S and blood vessels: an overview. Handb Exp Pharmacol. 2015;230:85\u2013110.","journal-title":"Handb Exp Pharmacol"},{"key":"2307_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejphar.2016.04.054","volume":"783","author":"SS El-Sayed","year":"2016","unstructured":"El-Sayed SS, Zakaria MN, Abdel-Ghany RH, Abdel-Rahman AA. Cystathionine-gamma lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic rats. Eur J Pharmacol. 2016;783:73\u201384.","journal-title":"Eur J Pharmacol"},{"key":"2307_CR19","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1159\/000373973","volume":"35","author":"X Zhong","year":"2015","unstructured":"Zhong X, Wang Y, Wu J, Sun A, Yang F, Zheng D, Li T, Dong S, Zhao Y, Yang G, Xu C, Sun D, Lu F, Zhang W. Calcium sensing receptor regulating smooth muscle cells proliferation through initiating cystathionine-gamma-lyase\/hydrogen sulfide pathway in diabetic rat. Cell Physiol Biochem. 2015;35:1582\u201398.","journal-title":"Cell Physiol Biochem"},{"key":"2307_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3892\/mmr.2016.5289","volume":"14","author":"F Li","year":"2016","unstructured":"Li F, Luo J, Wu Z, Xiao T, Zeng O, Li L, Li Y, Yang J. Hydrogen sulfide exhibits cardioprotective effects by decreasing endoplasmic reticulum stress in a diabetic cardiomyopathy rat model. Mol Med Rep. 2016;14:865\u201373.","journal-title":"Mol Med Rep"},{"key":"2307_CR21","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1681\/ASN.2008121269","volume":"20","author":"EM Bos","year":"2009","unstructured":"Bos EM, Leuvenink HG, Snijder PM, Kloosterhuis NJ, Hillebrands JL, Leemans JC, Florquin S, van Goor H. Hydrogen sulfide-induced hypometabolism prevents renal ischemia\/reperfusion injury. J Am Soc Nephrol. 2009;20:1901\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"2307_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10157-012-0670-y","volume":"17","author":"J Yamamoto","year":"2013","unstructured":"Yamamoto J, Sato W, Kosugi T, Yamamoto T, Kimura T, Taniguchi S, Kojima H, Maruyama S, Imai E, Matsuo S, Yuzawa Y, Niki I. Distribution of hydrogen sulfide (H(2)S)-producing enzymes and the roles of the H(2)S donor sodium hydrosulfide in diabetic nephropathy. Clin Exp Nephrol. 2013;17:32\u201340.","journal-title":"Clin Exp Nephrol"},{"key":"2307_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2017.08.012","volume":"265","author":"P Aghagolzadeh","year":"2017","unstructured":"Aghagolzadeh P, Radpour R, Bachtler M, van Goor H, Smith ER, Lister A, Odermatt A, Feelisch M, Pasch A. Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1\/NRF2\/NQO1 activation. Atherosclerosis. 2017;265:78\u201386.","journal-title":"Atherosclerosis"},{"key":"2307_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000348432","volume":"35","author":"K Shrivastava","year":"2013","unstructured":"Shrivastava K, Llovera G, Recasens M, Chertoff M, Gim\u00e9nez-Llort L, Gonzalez B, Acarin L. Temporal expression of cytokines and signal transducer and activator of transcription factor 3 activation after neonatal hypoxia\/ischemia in mice. Dev Neurosci. 2013;35:212\u201325.","journal-title":"Dev Neurosci"},{"key":"2307_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00395-010-0141-0","volume":"106","author":"S Demyanets","year":"2011","unstructured":"Demyanets S, Kaun C, Rychli K, Pfaffenberger S, Kastl SP, Hohensinner PJ, Rega G, Katsaros KM, Afonyushkin T, Bochkov VN, Paireder M, Huk I, Maurer G, Huber K, Wojta J. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1\/2- and STAT1\/STAT3-dependent pathways and is attenuated by interferon-gamma. Basic Res Cardiol. 2011;106:217\u201331.","journal-title":"Basic Res Cardiol"},{"key":"2307_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.111.00299","volume":"61","author":"AW Johnson","year":"2013","unstructured":"Johnson AW, Kinzenbaw DA, Modrick ML, Faraci FM. Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension. Hypertension. 2013;61:437\u201342.","journal-title":"Hypertension"},{"key":"2307_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.carpath.2006.07.001","volume":"16","author":"CL Simpson","year":"2007","unstructured":"Simpson CL, Lindley S, Eisenberg C, Basalyga DM, Starcher BC, Simionescu DT, Vyavahare NR. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol. 2007;16:29\u201337.","journal-title":"Cardiovasc Pathol"},{"key":"2307_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1432-1327.1998.2580001.x","volume":"258","author":"B Vrhovski","year":"1998","unstructured":"Vrhovski B, Weiss AS. Biochemistry of tropoelastin. Eur J Biochem. 1998;258:1\u201318.","journal-title":"Eur J Biochem"},{"key":"2307_CR29","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/jcb.25088","volume":"116","author":"Y Kakutani","year":"2015","unstructured":"Kakutani Y, Shioi A, Shoji T, Okazaki H, Koyama H, Emoto M, Inaba M. Oncostatin M Promotes Osteoblastic differentiation of human vascular smooth muscle cells through JAK3-STAT3 pathway. J Cell Biochem. 2015;116:1325\u201333.","journal-title":"J Cell Biochem"},{"key":"2307_CR30","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.108.827972","volume":"119","author":"E Aikawa","year":"2009","unstructured":"Aikawa E, Aikawa M, Libby P, Figueiredo JL, Rusanescu G, Iwamoto Y, Fukuda D, Kohler RH, Shi GP, Jaffer FA, Weissleder R. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation. 2009;119:1785\u201394.","journal-title":"Circulation"},{"key":"2307_CR31","first-page":"1337","volume":"10","author":"Z Gong","year":"2018","unstructured":"Gong Z, Ye H, Huo Y, Wang L, Huang Y, Huang M, Yuan X. S-allyl-cysteine attenuates carbon tetrachloride-induced liver fibrosis in rats by targeting STAT3\/SMAD3 pathway. Am J Transl Res. 2018;10:1337\u201346.","journal-title":"Am J Transl Res"},{"key":"2307_CR32","doi-asserted-by":"publisher","first-page":"21220","DOI":"10.18632\/aging.103827","volume":"12","author":"F He","year":"2020","unstructured":"He F, Li L, Li PP, Deng Y, Yang YY, Deng YX, Luo HH, Yao XT, Su YX, Gan H, He BC. Cyclooxygenase-2\/sclerostin mediates TGF-beta1-induced calcification in vascular smooth muscle cells and rats undergoing renal failure. Aging (Albany NY). 2020;12:21220\u201335.","journal-title":"Aging (Albany NY)"},{"key":"2307_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bbrc.2005.06.119","volume":"334","author":"A Simionescu","year":"2005","unstructured":"Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun. 2005;334:524\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"2307_CR34","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1016\/S0021-9258(19)49931-6","volume":"267","author":"M Swaroop","year":"1992","unstructured":"Swaroop M, Bradley K, Ohura T, Tahara T, Roper MD, Rosenberg LE, Kraus JP. Rat cystathionine beta-synthase. Gene organization and alternative splicing. J Biol Chem. 1992;267:11455\u201361.","journal-title":"J Biol Chem"},{"key":"2307_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1046\/j.1523-1755.2003.00068.x","volume":"64","author":"R Merjanian","year":"2003","unstructured":"Merjanian R, Budoff M, Adler S, Berman N, Mehrotra R. Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease. Kidney Int. 2003;64:263\u201371.","journal-title":"Kidney Int"},{"key":"2307_CR36","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/ndt\/gfl429","volume":"21","author":"NX Chen","year":"2006","unstructured":"Chen NX, Duan D, O\u2019Neill KD, Moe SM. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant. 2006;21:3435\u201342.","journal-title":"Nephrol Dial Transplant"},{"key":"2307_CR37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415\u201321.","journal-title":"Science"},{"key":"2307_CR38","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.278.5343.1630","volume":"277","author":"A Kumar","year":"1997","unstructured":"Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. STATs and gene regulation. Science. 1997;277:1630\u20135.","journal-title":"Science"},{"key":"2307_CR39","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00125-012-2594-1","volume":"55","author":"Y Chen","year":"2012","unstructured":"Chen Y, Wang JJ, Li J, Hosoya KI, Ratan R, Townes T, Zhang SX. Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes. Diabetologia. 2012;55:2533\u201345.","journal-title":"Diabetologia"},{"key":"2307_CR40","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbrc.2004.08.014","volume":"322","author":"L Li","year":"2004","unstructured":"Li L, Shaw PE. A STAT3 dimer formed by inter-chain disulphide bridging during oxidative stress. Biochem Biophys Res Commun. 2004;322:1005\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"2307_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-017-0621-z","volume":"16","author":"SA Ibrahim","year":"2017","unstructured":"Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, G\u00f6tte M. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6\/STAT3, Notch and EGFR signaling pathways. Mol Cancer. 2017;16:57.","journal-title":"Mol Cancer"},{"key":"2307_CR42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00592-014-0706-8","volume":"52","author":"WB Li","year":"2015","unstructured":"Li WB, Zhao J, Liu L, Wang ZH, Han L, Zhong M, Zhang Y, Zhang W, Tang MX. Silencing of activin receptor-like kinase 7 alleviates aortic stiffness in type 2 diabetic rats. Acta Diabetol. 2015;52:717\u201326.","journal-title":"Acta Diabetol"},{"key":"2307_CR43","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.ajpath.2014.11.026","volume":"185","author":"JL Figueiredo","year":"2015","unstructured":"Figueiredo JL, Aikawa M, Zheng C, Aaron J, Lax L, Libby P, de Lima Filho JL, Gruener S, Fingerle J, Haap W, Hartmann G, Aikawa E. Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease. Am J Pathol. 2015;185:1156\u201366.","journal-title":"Am J Pathol"},{"key":"2307_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.immuni.2005.09.010","volume":"23","author":"H Kitamura","year":"2005","unstructured":"Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, Murakami M, Hirano T. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity. 2005;23:491\u2013502.","journal-title":"Immunity"},{"key":"2307_CR45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbi.2018.07.005","volume":"73","author":"L Cao","year":"2018","unstructured":"Cao L, Cao X, Zhou Y, Nagpure BV, Wu ZY, Hu LF, Yang Y, Sethi G, Moore PK, Bian JS. Hydrogen sulfide inhibits ATP-induced neuroinflammation and Abeta(1\u201342) synthesis by suppressing the activation of STAT3 and cathepsin S. Brain Behav Immun. 2018;73:603\u201314.","journal-title":"Brain Behav Immun"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-02307-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-02307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T17:04:18Z","timestamp":1634144658000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-02307-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2307"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-02307-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal protocols were approved by the Experimental Animal Care and Use Committee of Nanjing Medical University, and we complied with the Guide for the Care and Use of Laboratory Animals (NIH publication, 8th edition, 2011), and the study was carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}